ECARX Holdings Inc. reported unaudited financial results for the third quarter of 2025, achieving a net profit of $0.9 million, compared to a net loss of $47.2 million in the same period last year. Adjusted EBITDA was $8.3 million, up from a loss of $31.9 million year-over-year. Research and development expenses decreased by 46% to $25.9 million, while selling, general and administrative expenses fell by 37% to $18.4 million. Total cash as of September 30, 2025, was $50.4 million. Business developments during the period included continued global expansion and enhanced supply chain efficiency, contributing to increased shipment volumes and improved gross margins.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ECARDX Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001136552-en) on November 03, 2025, and is solely responsible for the information contained therein.
Comments